Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec;36(12):1050-1061.
doi: 10.1089/dna.2017.3853. Epub 2017 Sep 25.

Implications of Sortilin in Lipid Metabolism and Lipid Disorder Diseases

Anbo Gao  1 , Francisco S Cayabyab  2 , Xi Chen  1 , Jing Yang  3 , Li Wang  1 , Tianhong Peng  1 , Yuncheng Lv  1   2
Affiliations
Review

Implications of Sortilin in Lipid Metabolism and Lipid Disorder Diseases

Anbo Gao et al. DNA Cell Biol. 2017 Dec.

Abstract

The present review provides a summary of recent evidence of sortilin expression, function, and regulation and its implications in lipid metabolism and development of lipid disorder diseases. As a member of the vacuolar protein sorting 10 protein (Vps10p) receptor family, sortilin mediates intracellular trafficking of diverse endogenous or exogenous protein substrates between the trans-Golgi network (TGN) and plasma membrane compartments. Recent studies reveal that sortilin regulates the expression of lipid genes, plasma lipid level, and the development of lipid disorder diseases. Sortilin promotes atherogenesis by regulating hepatic very low density lipoprotein (VLDL) secretion and plasma lipid level and subsequently macrophage lipid accumulation. Sortilin deficiency is caused by accelerated proteasome degradation under insulin resistance conditions and is thereby implicated in the hyperlipidemia of type 2 diabetes mellitus (T2DM). Sortilin facilitates hepatic cholesterol accumulation by inhibiting hepatic cholesterol catabolism, which promotes the development of nonalcoholic fatty liver disease (NAFLD). Sortilin plays an important role in lipid metabolism and represents a promising therapeutic target for lipid disorder diseases.

Keywords: atherosclerosis; lipid metabolism; nonalcoholic fatty liver disease; sortilin; type 2 diabetes mellitus.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Neurotensin pathway in digestive cancers and clinical applications: an overview.
    Christou N, Blondy S, David V, Verdier M, Lalloué F, Jauberteau MO, Mathonnet M, Perraud A. Christou N, et al. Cell Death Dis. 2020 Dec 2;11(12):1027. doi: 10.1038/s41419-020-03245-8. Cell Death Dis. 2020. PMID: 33268796 Free PMC article. Review.
  • Serum Sortilin Levels as a Biomarker for Metabolic and Hormonal Dysregulation in Polycystic Ovary Syndrome.
    Alarslan P, Doruk M. Alarslan P, et al. J Pers Med. 2025 Feb 15;15(2):70. doi: 10.3390/jpm15020070. J Pers Med. 2025. PMID: 39997347 Free PMC article.
  • Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer.
    Bojmar L, Zambirinis CP, Hernandez JM, Chakraborty J, Shaashua L, Kim J, Johnson KE, Hanna S, Askan G, Burman J, Ravichandran H, Zheng J, Jolissaint JS, Srouji R, Song Y, Choubey A, Kim HS, Cioffi M, van Beek E, Sigel C, Jessurun J, Velasco Riestra P, Blomstrand H, Jönsson C, Jönsson A, Lauritzen P, Buehring W, Ararso Y, Hernandez D, Vinagolu-Baur JP, Friedman M, Glidden C, Firmenich L, Lieberman G, Mejia DL, Nasar N, Mutvei AP, Paul DM, Bram Y, Costa-Silva B, Basturk O, Boudreau N, Zhang H, Matei IR, Hoshino A, Kelsen D, Sagi I, Scherz A, Scherz-Shouval R, Yarden Y, Oren M, Egeblad M, Lewis JS, Keshari K, Grandgenett PM, Hollingsworth MA, Rajasekhar VK, Healey JH, Björnsson B, Simeone DM, Tuveson DA, Iacobuzio-Donahue CA, Bromberg J, Vincent CT, O'Reilly EM, DeMatteo RP, Balachandran VP, D'Angelica MI, Kingham TP, Allen PJ, Simpson AL, Elemento O, Sandström P, Schwartz RE, Jarnagin WR, Lyden D. Bojmar L, et al. Nat Med. 2024 Aug;30(8):2170-2180. doi: 10.1038/s41591-024-03075-7. Epub 2024 Jun 28. Nat Med. 2024. PMID: 38942992 Free PMC article.
  • SUMOylation targeting mitophagy in cardiovascular diseases.
    Xiao H, Zhou H, Zeng G, Mao Z, Zeng J, Gao A. Xiao H, et al. J Mol Med (Berl). 2022 Nov;100(11):1511-1538. doi: 10.1007/s00109-022-02258-4. Epub 2022 Sep 26. J Mol Med (Berl). 2022. PMID: 36163375 Review.
  • New Players in Metabolic Syndrome.
    Nedeva I, Assyov Y, Karamfilova V, Kamenov Z, Dobrev P, Velikova T, Vodenicharov V. Nedeva I, et al. Metabolites. 2025 Jun 9;15(6):380. doi: 10.3390/metabo15060380. Metabolites. 2025. PMID: 40559404 Free PMC article.
See all "Cited by" articles

MeSH terms

Substances